Technical Analysis
Comprehensive insights into market trends, chart patterns, and key indicators. Equip yourself with the tools and strategies to make data-driven trading decisions.
Biogen’s Q4 earnings are expected to show 1% year-on-year revenue growth to $2.41 billion, with EPS projected at $3.36. While analysts remain confident, Biogen’s recent stock decline warrants attention alongside peer performance comparisons.
Biogen Earnings Preview: Q4 Revenue and Growth Projections Read More »
Fed Chair Powell hints at revisions to the “dot plot” interest rate projections, aiming to improve communication clarity. The review examines the dot plot’s efficacy and explores ways to better convey policy intentions to the market.
Rethinking the Fed’s Dot Plot: A Potential Shift in Monetary Policy Communication Read More »
US stocks fell on March 21st as investors awaited Nvidia’s earnings and worried about Trump’s tariffs. The S&P 500 and Nasdaq dropped 0.5% and 1.2%, respectively, amid trade uncertainty.
US Stock Market Closes Lower Amid Tariff Concerns and Nvidia Earnings Anticipation Read More »
Navigate the 2025 market with BlackRock’s focus on quality growth investments. Prioritize strong fundamentals, sustainable growth potential, and adapt to evolving micro-narratives for optimal returns.
Navigating the 2025 Market: BlackRock’s Insights on Quality and Growth Read More »
Efruxifermin shows promise reversing cirrhosis in MASH patients in a Phase 2b trial. 39% of patients saw cirrhosis reversal, offering hope for this severe liver disease with limited treatment options.
Akero Therapeutics Stock Soars on Promising Liver Disease Drug Trial Read More »
Hyperloop Capital Insights offers tailored investment plans for all experience levels, from beginner to expert. Access tools, resources, and market insights to achieve your financial goals with Free, Bronze, Silver, or Gold plans.
Hyperloop Capital Insights: Unlocking Investment Opportunities with Tailored Plans Read More »
Oxford Industries (OXM) reports Q3 earnings tomorrow, with analysts projecting a 3% revenue decline to $316.8M and EPS of $0.09. Can OXM beat expectations despite missing revenue projections in the previous quarter?
Oxford Industries (OXM) Q3 Earnings Preview: Key Insights for Investors Read More »
Canada’s services sector contracted in December 2024, ending a three-month growth streak. A postal strike and weak demand contributed to the decline, pushing the S&P Global Canada Services PMI below 50.
Canadian Services Sector Contracts in December Amid Postal Strike Read More »
US stocks showed mixed results as investors await key economic data like the December CPI report. The Dow gained, while the S&P 500 saw a slight rise and the Nasdaq dipped, reflecting market uncertainty around inflation and potential policy implications.
US Stocks Mixed as Investors Await Key Economic Data Read More »
Merck plans to significantly expand its India workforce to ~2,700 by end-2024, doubling or more in the following two years. This growth focuses on “digital innovators” to accelerate new treatment development and solidifies Merck’s presence in India.
Merck Plans Significant Workforce Expansion in India Read More »
